Forecast: Import of Medicaments Mixed Together for Therapeutic Use to Argentina

Looking back at the actual import figures for medicaments mixed together for therapeutic use to Argentina, the value in 2023 was recorded at 38.32 million USD. The forecast for 2024 is 36.608 million USD, implying a year-on-year decrease of 4.48%. For 2025, the value is expected to further drop to 34.882 million USD, reflecting a decrement of 4.71%. The forecast for the subsequent years continues this downward trend with values of 33.192 million USD in 2026 (a decline of 4.85%), 31.535 million USD in 2027 (a decrease of 4.99%), and 29.911 million USD in 2028 (a further drop of 5.15%). The Compound Annual Growth Rate (CAGR) over this five-year forecast period is approximately -4.84%.

Future trends to watch for include potential regulatory changes in Argentina’s pharmaceutical import policies, shifts in domestic production capabilities, currency fluctuations impacting import costs, and evolving healthcare needs driven by demographic changes. Monitoring these factors will be essential for understanding and anticipating further movements in the market value of these imports.